There are new treatments to help patients with glaucoma, and they’re just in time. The disease is the second leading cause of ...

A £1.8m study aimed at helping to improve diagnosis of an eye condition that can lead to sight loss is to be carried out at ...

Resveratrol supplementation with selective laser trabeculoplasty may be an effective treatment option for glaucoma by ...

Glaucoma is a common eye condition that can affect people as they age, especially those over 60. It damages the optic nerve, ...

Bausch + Lomb acquired Whitecap Biosciences, including its two therapies for potential use in glaucoma and geographic atrophy ...

For the second year in a row, Bausch + Lomb has joined with the Glaucoma Research Foundation to launch the “Faces of Glaucoma ...

More than 3 million people in the U.S. are estimated to be living with glaucoma. By 2030, that number is expected to increase ...

Glaucoma can occur in children, although it is rare. Early diagnosis and treatment are essential to prevent permanent vision loss. Glaucoma is an eye condition that damages the optic nerve.

GlobalData predicts that six late-stage pipeline products are set to enter the glaucoma market during the forecast period.

Seven-Market Drug Forecast Analysis - Update" report has been added to ResearchAndMarkets.com's offering. Market Growth Driven by Aging Populations and Innovative TherapiesThe global glaucoma market ...

Optegra Eye Hospital Manchester, located in Didsbury, has launched a new NHS glaucoma treatment pathway aimed at reducing ...

Glaucoma is the term for a group of eye conditions that damage the optic nerve at the back of the eye. Without treatment, it can lead to vision loss and blindness. Glaucoma is not a life ...